» Articles » PMID: 30653248

Risk of Parkinson's Disease Dementia Related to Level I MDS PD-MCI

Abstract

Background: The International Parkinson and Movement Disorders Society criteria for mild cognitive impairment in PD need validation. The objectives of this present study were to evaluate prognostic validity of level I (abbreviated) International Parkinson and Movement Disorders Society mild cognitive impairment in PD criteria for development of PD dementia and compared them with level II (comprehensive) criteria.

Methods: We analyzed data from 8 international studies (1045 patients) from our consortium that included baseline data on demographics, motor signs, depression, detailed neuropsychological testing, and longitudinal follow-up for conversion to Parkinson's disease dementia. Survival analysis evaluated their contribution to the hazard of Parkinson's disease dementia.

Results: Level I mild cognitive impairment in PD, increasing age, male sex, and severity of PD motor signs independently increased the hazard of Parkinson's disease dementia. Level I and level II mild cognitive impairment in PD classification had similar discriminative ability with respect to the time to Parkinson's disease dementia.

Conclusions: Level I mild cognitive impairment in PD classification independently contributes to the hazard of Parkinson's disease dementia. This finding supports the prognostic validity of the abbreviated mild cognitive impairment in PD criteria. © 2019 International Parkinson and Movement Disorder Society.

Citing Articles

Twenty-Three-Year Mortality in Parkinson's Disease: A Population-Based Prospective Study (NEDICES).

Benito-Rodriguez C, Bermejo-Pareja F, Berbel A, Lapena-Motilva J, Benito-Leon J J Clin Med. 2025; 14(2).

PMID: 39860502 PMC: 11765759. DOI: 10.3390/jcm14020498.


α-Synuclein Oligomers in Skin Biopsies Predict the Worsening of Cognitive Functions in Parkinson's Disease: A Single-Center Longitudinal Cohort Study.

Contaldi E, Basellini M, Mazzetti S, Calogero A, Colombo A, Cereda V Int J Mol Sci. 2024; 25(22).

PMID: 39596242 PMC: 11594322. DOI: 10.3390/ijms252212176.


Investigating underlying brain structures and influence of mild and subjective cognitive impairment on dual-task performance in people with Parkinson's disease.

Albrecht F, Johansson H, Ekman U, Poulakis K, Bezuidenhout L, Pereira J Sci Rep. 2024; 14(1):9513.

PMID: 38664471 PMC: 11045833. DOI: 10.1038/s41598-024-60050-5.


Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study.

Joza S, Hu M, Jung K, Kunz D, Arnaldi D, Lee J Alzheimers Dement. 2023; 20(1):91-102.

PMID: 37461299 PMC: 10917000. DOI: 10.1002/alz.13386.


Detection of mild cognitive impairment in Parkinson's disease using gradient boosting decision tree models based on multilevel DTI indices.

Chen B, Xu M, Yu H, He J, Li Y, Song D J Transl Med. 2023; 21(1):310.

PMID: 37158918 PMC: 10165759. DOI: 10.1186/s12967-023-04158-8.